RTI Surgical Inc. Receives FDA IDE Approval for the Clinical Investigation of Cortiva(R) Allograft Dermis in Breast Reconstruction

ALACHUA, Fla., Nov. 27, 2023 -- (Healthcare Sales & Marketing Network) -- RTI Surgical, a leading global medical device organization, announced that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval fo... Devices, Surgery RTI Surgical, Cortiva, Allograft Dermis, breast reconstruction

https://salesandmarketingnetwork.com/news_release_bs.html?ID=2048144

Source: HSMN NewsFeed - November 27, 2023 Category: Pharmaceuticals Source Type: news

More News: Bone Graft | Food and Drug Administration (FDA) | Marketing | Medical Devices | Pharmaceuticals